LBX Pharmacy Chain Balance Sheet Health
Financial Health criteria checks 4/6
LBX Pharmacy Chain has a total shareholder equity of CN¥7.5B and total debt of CN¥4.0B, which brings its debt-to-equity ratio to 53.4%. Its total assets and total liabilities are CN¥21.2B and CN¥13.7B respectively. LBX Pharmacy Chain's EBIT is CN¥1.4B making its interest coverage ratio 14.8. It has cash and short-term investments of CN¥2.1B.
Key information
53.4%
Debt to equity ratio
CN¥4.03b
Debt
Interest coverage ratio | 14.8x |
Cash | CN¥2.10b |
Equity | CN¥7.55b |
Total liabilities | CN¥13.66b |
Total assets | CN¥21.21b |
Recent financial health updates
Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?
Sep 02LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly
May 21Recent updates
We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings
Nov 06LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Sep 06Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?
Sep 02Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper
Jul 03Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching
Jun 08LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly
May 21There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding
Apr 22Financial Position Analysis
Short Term Liabilities: 603883's short term assets (CN¥8.6B) do not cover its short term liabilities (CN¥10.1B).
Long Term Liabilities: 603883's short term assets (CN¥8.6B) exceed its long term liabilities (CN¥3.5B).
Debt to Equity History and Analysis
Debt Level: 603883's net debt to equity ratio (25.6%) is considered satisfactory.
Reducing Debt: 603883's debt to equity ratio has increased from 34.6% to 53.4% over the past 5 years.
Debt Coverage: 603883's debt is well covered by operating cash flow (63.4%).
Interest Coverage: 603883's interest payments on its debt are well covered by EBIT (14.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 16:21 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LBX Pharmacy Chain Joint Stock Company is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yue Gao | Changjiang Securities Co. LTD. |
Qianyi Li | China International Capital Corporation Limited |
Yong Jian Li | China Merchants Securities Co. Ltd. |